Substance Use Disorders
January 5, 2024 -
 September 20, 2024
1st, 2nd, and 3rd Fridays
12:00 PM -
 1:00 PM

Thank you for your interest in SUD! We are currently on hiatus but will announce registration details for the upcoming series. Please stay tuned for updates, which will be sent via email.

In 2022, a staggering number of Americans aged 12 and older – 168.7 million people, or 59.8% – reported using tobacco products, vaping nicotine, consuming alcohol, or using illicit drugs within the past month. This includes 137.4 million individuals who drank alcohol, 50.9 million who used tobacco products, 23.5 million who vaped nicotine, and 46.6 million who used illicit drugs.

To effectively manage and support individuals with substance use disorders, healthcare providers must stay informed. Join our ECHO series led by medical experts and psychiatrists from the esteemed New Jersey Medical School and Rowan Medicine. Our series offers a safe space for peer-to-peer learning and open dialogue, providing up-to-date best practices, current research, and new trends in this field.

Through our sessions, you will gain valuable insights into screening and management of substance use disorders in primary care, integrating treatment options, and creating a stigma-free environment for your patients. By equipping yourself with the knowledge and tools offered in our series, you can make a significant difference in the lives of individuals with substance use disorders.

Series Leaders

SUD Sessions

  • Rashi Aggarwal, MD, FACLP, DFAPA, Professor, Vice Chair for Education and Director, Residency Training Program, Rutgers New Jersey Medical School
  • Allison Dinar, MD, Psychiatry Resident, Rutgers New Jersey Medical School
  • Petros Levounis, MD, MA, Professor and Chair, Department of Psychiatry, Rutgers New Jersey Medical School
  • Isaac Song, MD, Psychiatry Resident, Rutgers New Jersey Medical School
  • Hojun Yoo, MD, Psychiatry Resident, Rutgers New Jersey Medical School

 

MAT/CQI Sessions

  • Mohammad Addar, Master Black Belt, Operational Excellence, Cooper University Health Care
  • James Bailey, DO, Assistant Professor at RowanSOM and Medical Director of the NeuroMusculoskeletal Institute (NMI)
  • Clement Chen, PharmD, Clinical Pharmacist/Academic Detailer, Rutgers New Jersey Medical School
  • Rachel Flumo, B.A., MPH, Training Coordinator, Northern NJ Medication-Assisted Treatment Center of Excellence, Department of Psychiatry, Rutgers New Jersey Medical School
  • La-Tricia Gordon, RN, CARN, CALA/Academic Detailer, Department of Psychiatry, Rutgers New Jersey Medical School

Learning Objectives

After participating in ECHO, providers will be able to:

  • Describe screening, management, and treatment options for substance use disorders in primary care settings.
  • Apply evidence-based strategies to initiate and integrate substance use disorder treatment within a primary care setting.
  • Employ approaches to cultivate a stigma-free and supportive atmosphere when coordinating and managing care for patients with substance use disorders.
  • Identify and recommend appropriate community resources to support patients with substance use disorders in their recovery journey.

Continuing Education Accreditation

To view the CE Accreditation for CME, CNE, CPE, Licensed and Certified Drug and Alcohol Counselors, Certified Recovery Support Practitioner, and Social Work credits, click here.

 

Additional Information

Information regarding substance use in the United States during 2022 was obtained from HHS, SAMHSA National Survey on Drug and Health Data. To read more, click here.

Information regarding increased use of substances during the pandemic was obtained from the Kaiser Family Foundation. To read more, click here.

2024 SUD ECHO Series Flyer

Submit a clinical case or patient scenario to be presented during an ECHO session and receive a $100 gift card*. Your valuable contributions provide a learning opportunity for others.

Click here to access the submission forms:

SUD/MAT

CQI

Sessions

Screening for Addiction in Pain Patients
Friday • January 05, 2024
12:00 PM
- 1:00 PM
Quality Improvement Applications: Case Study 1
Friday • January 12, 2024
12:00 PM
- 1:00 PM
Preventing SUD: Vaping Awareness
Friday • January 19, 2024
12:00 PM
- 1:00 PM
Safe and Effective Withdrawal Management in Buprenorphine Induction  
Friday • February 02, 2024
12:00 PM
- 1:00 PM
Quality Improvement Applications: Case Study 2
Friday • February 09, 2024
12:00 PM
- 1:00 PM
Eating Disorders & SUD
Friday • February 16, 2024
12:00 PM
- 1:00 PM
How to Choose-Full Agonist vs. Partial Agonist
Friday • March 01, 2024
12:00 PM
- 1:00 PM
Gambling & SUD
Friday • March 29, 2024
12:00 PM
- 1:00 PM
Practicing Cultural Humility in Management of OUD
Friday • April 05, 2024
12:00 PM
- 1:00 PM
Quality Improvement Applications: Case Study 4
Friday • April 12, 2024
12:00 PM
- 12:00 PM
Cluster B Personality Disorders & SUD
Friday • April 19, 2024
12:00 PM
- 1:00 PM
Managing Pain Post-Op-Transitions to Ambulatory Care
Friday • May 03, 2024
12:00 PM
- 1:00 PM
Quality Improvement Applications: Case Study 5
Friday • May 10, 2024
12:00 PM
- 1:00 PM
Addressing SUD through Trauma Informed Care
Friday • May 17, 2024
12:00 PM
- 1:00 PM
Increasing Patient Access to SUD Services: Where Do We Go from Here
Friday • June 07, 2024
12:00 PM
- 1:00 PM
Quality Improvement Applications: Case Study 6 
Friday • June 14, 2024
12:00 PM
- 1:00 PM
PTSD and Social Support in SUD
Friday • June 28, 2024
12:00 PM
- 1:00 PM
Alternatives to Opioid Therapy for Patients with a History of SUD
Friday • July 12, 2024
12:00 PM
- 1:00 PM
Quality Improvement Applications: Case Study 7
Friday • July 19, 2024
12:00 PM
- 1:00 PM
Role of the Integrated Care Setting in Sustained Recovery
Friday • July 26, 2024
1:00 PM
- 1:00 PM
Quality Improvement Applications: Case Study 8
Friday • August 09, 2024
12:00 PM
- 1:00 PM
Digital Addiction & SUD
Friday • August 16, 2024
12:00 PM
- 1:00 PM
Integrated Care for OUD and Co-occurring Illicit Substance Use  
Friday • August 23, 2024
12:00 PM
- 1:00 PM
Supporting Reentry: Drug Treatment for Formerly Incarcerated Individuals 
Friday • September 06, 2024
12:00 PM
- 1:00 PM
Quality Improvement Applications: Case Study 9
Friday • September 13, 2024
12:00 PM
- 1:00 PM
Xylazine Update & Other Designer Drugs
Friday • September 20, 2024
12:00 PM
- 1:00 PM